Qatar vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Qatar
100.0%
in 2024
Sur
82.0%
in 2024
Qatar rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Qatar
- Sur
How they compare
Qatar currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Qatar's figure about 1.2 times Sur's.
Across all 9 years both countries report, Qatar has been ahead every year.
Qatar ranks 1st and Sur ranks 2nd of 144 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.0% | 68.0% | Qatar |
| 2010s | 100.0% | 79.0% | 21.0% | Qatar |
| 2020s | 100.0% | 75.8% | 24.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Qatar or Sur?
- Qatar, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Qatar and Sur?
- 18.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Sur?
- 9 years are reported by both, from 2008 to 2024.
- How do Qatar and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Qatar ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.